title: Chronic myelogenous leukemia for primary care physicians.
authors.affiliation: Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.
authors.forename: Sara R
authors.initials: SR
authors.lastname: Torgerson
authors.forename: Rami Y
authors.initials: RY
authors.lastname: Haddad
authors.forename: Ehab
authors.initials: E
authors.lastname: Atallah
mesh_terms: D001549:Benzamides; D044963:Biopsy, Fine-Needle; D001853:Bone Marrow / Q000473:pathology; D000069439:Dasatinib; D018450:Disease Progression; D005260:Female; D016044:Fusion Proteins, bcr-abl / Q000235:genetics; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000175:diagnosis* / Q000188:drug therapy* / Q000453:epidemiology / Q000235:genetics; D007964:Leukocytosis / Q000209:etiology; D010677:Philadelphia Chromosome; D010879:Piperazines / Q000627:therapeutic use; D010976:Platelet Count; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic; D011320:Primary Health Care; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D013844:Thiazoles / Q000627:therapeutic use; D014178:Translocation, Genetic
chemical_list: D001549:Benzamides; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D013844:Thiazoles; D000068877:Imatinib Mesylate; D016044:Fusion Proteins, bcr-abl; C498826:nilotinib; D000069439:Dasatinib